- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical trials of human papillomavirus vaccines and beyond
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume 10, Issue 7, Pages 400-410
Publisher
Springer Nature
Online
2013-06-04
DOI
10.1038/nrclinonc.2013.84
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia–Grade 2
- (2014) Philip E. Castle et al. OBSTETRICS AND GYNECOLOGY
- Comparing the performance of six human papillomavirus tests in a screening population
- (2013) J Cuzick et al. BRITISH JOURNAL OF CANCER
- Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study
- (2013) Amy Leval et al. JNCI-Journal of the National Cancer Institute
- HPV16 Seropositivity and Subsequent HPV16 Infection Risk in a Naturally Infected Population: Comparison of Serological Assays
- (2013) Shih-Wen Lin et al. PLoS One
- High-Throughput Monitoring of Human Papillomavirus Type Distribution
- (2012) A. Soderlund-Strand et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Occurrence of vaccine and non-vaccine human papillomavirus types in adolescent Finnish females 4 years post-vaccination
- (2012) Johanna Palmroth et al. INTERNATIONAL JOURNAL OF CANCER
- Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer
- (2012) Gordana Halec et al. INTERNATIONAL JOURNAL OF CANCER
- Understanding long-term protection of human papillomavirus vaccination against cervical carcinoma: Cancer registry-based follow-up
- (2012) Muhammad Mohsin Rana et al. INTERNATIONAL JOURNAL OF CANCER
- Development of AAVLP(HPV16/31L2) Particles as Broadly Protective HPV Vaccine Candidate
- (2012) Karen Nieto et al. PLoS One
- Updating the Natural History of Human Papillomavirus and Anogenital Cancers
- (2012) Anna-Barbara Moscicki et al. VACCINE
- Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark
- (2012) B. Pasternak et al. BMJ-British Medical Journal
- Evaluation of the HPV 18 antibody response in Gardasil®vaccinees after 48 mo using a pseudovirion neutralization assay
- (2012) Christine Roberts et al. Human Vaccines & Immunotherapeutics
- Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine
- (2012) Cecilia M. Roteli-Martins et al. Human Vaccines & Immunotherapeutics
- Sound efficacy of prophylactic HPV vaccination
- (2012) Matti Lehtinen et al. OncoImmunology
- Long term protection against cervical infection with the human papillomavirus: Review of currently available vaccines
- (2011) Barbara Romanowski Human vaccines & immunotherapeutics
- Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18
- (2011) A. Szarewski et al. INTERNATIONAL JOURNAL OF CANCER
- Clustering of Multiple Human Papillomavirus Infections in Women From a Population-Based Study in Guanacaste, Costa Rica
- (2011) Salvatore Vaccarella et al. JOURNAL OF INFECTIOUS DISEASES
- Clustering of Human Papillomavirus (HPV) Types in the Male Genital Tract: The HPV in Men (HIM) Study
- (2011) Salvatore Vaccarella et al. JOURNAL OF INFECTIOUS DISEASES
- Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine
- (2011) C. Chao et al. JOURNAL OF INTERNAL MEDICINE
- Just implementation of human papillomavirus vaccination
- (2011) Erik Malmqvist et al. JOURNAL OF MEDICAL ETHICS
- Addressing the vaccine confidence gap
- (2011) Heidi J Larson et al. LANCET
- Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda
- (2011) Maria J Wawer et al. LANCET
- Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
- (2011) Julia ML Brotherton et al. LANCET
- Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial
- (2011) Aimée R Kreimer et al. LANCET ONCOLOGY
- Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Matti Lehtinen et al. LANCET ONCOLOGY
- Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Cosette M Wheeler et al. LANCET ONCOLOGY
- Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
- (2011) Anna R. Giuliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia
- (2011) Joel M. Palefsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia
- (2011) M. Lehtinen et al. SEXUALLY TRANSMITTED INFECTIONS
- Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera
- (2011) Eve Draper et al. VACCINE
- Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes
- (2011) Samuele Calabro et al. VACCINE
- Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica
- (2011) R. Herrero et al. Cancer Discovery
- Incidence, Duration, and Reappearance of Type-Specific Cervical Human Papillomavirus Infections in Young Women
- (2010) R. P. Insinga et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Human Papillomavirus Infection and Reinfection in Adult Women: the Role of Sexual Activity and Natural Immunity
- (2010) H. Trottier et al. CANCER RESEARCH
- Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33
- (2010) Marko Merikukka et al. INTERNATIONAL JOURNAL OF CANCER
- Judging the carcinogenicity of human papillomavirus types by single/multiple infection ratio in cervical cancer
- (2010) Gary M. Clifford et al. INTERNATIONAL JOURNAL OF CANCER
- Long-term persistence of systemic and mucosal immune response to HPV-16/18 AS04-adjuvanted vaccine in preteen/adolescent girls and young women
- (2010) Tiina Petäjä et al. INTERNATIONAL JOURNAL OF CANCER
- Coverage and Compliance of Human Papillomavirus Vaccines in Paris: Demonstration of Low Compliance With Non-School-Based Approaches
- (2010) Roman Rouzier et al. JOURNAL OF ADOLESCENT HEALTH
- Safety and Immunogenicity of the Quadrivalent Human Papillomavirus Vaccine in HIV‐1–Infected Men
- (2010) Timothy Wilkin et al. JOURNAL OF INFECTIOUS DISEASES
- Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
- (2010) Nubia Muñoz et al. JNCI-Journal of the National Cancer Institute
- Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data
- (2010) Basil Donovan et al. LANCET INFECTIOUS DISEASES
- IL-4 directs both CD4 and CD8 T cells to produce Th2 cytokines in vitro, but only CD4 T cells produce these cytokines in response to alum-precipitated protein in vivo
- (2010) Karine Serre et al. MOLECULAR IMMUNOLOGY
- Sustained Efficacy of the Pentavalent Rotavirus Vaccine, RV5, up to 3.1 Years Following the Last Dose of Vaccine
- (2010) Timo Vesikari et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007–2008
- (2010) La'Shan D. Taylor et al. PREVENTIVE MEDICINE
- Natural seroconversion to high-risk human papillomaviruses (hrHPVs) is not protective against related HPV genotypes
- (2010) Johanna Palmroth et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Risk of being seropositive for multiple human papillomavirus types among Finnish and Ugandan women
- (2010) Proscovia Bazanya Namujju et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Cancers attributable to human papillomavirus infection
- (2010) Andrew E. Grulich et al. Sexual Health
- Characterization of the HPV-specific memory B cell and systemic antibody responses in women receiving an unadjuvanted HPV16 L1 VLP vaccine
- (2010) Joseph G. Dauner et al. VACCINE
- HPV - immune response to infection and vaccination
- (2010) Margaret Stanley Infectious Agents and Cancer
- A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
- (2009) S. K. Kjaer et al. Cancer Prevention Research
- Prospects for new human papillomavirus vaccines
- (2009) Margaret Stanley CURRENT OPINION IN INFECTIOUS DISEASES
- Impact of human papillomavirus vaccination depends on effective vaccination strategy
- (2009) Matti Lehtinen et al. INTERNATIONAL JOURNAL OF CANCER
- Population dynamics of serologically identified coinfections with human papillomavirus types 11, 16, 18 and 31 in fertile-aged Finnish women
- (2009) Marjo Kaasila et al. INTERNATIONAL JOURNAL OF CANCER
- Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma?
- (2009) Anders Näsman et al. INTERNATIONAL JOURNAL OF CANCER
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years
- (2009) Darron R. Brown et al. JOURNAL OF INFECTIOUS DISEASES
- Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline
- (2009) Mark Schiffman et al. Infectious Agents and Cancer
- Is Smoking an Independent Risk Factor for Invasive Cervical Cancer? A Nested Case-Control Study Within Nordic Biobanks
- (2008) A. S. Kapeu et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years
- (2008) Tiina Petäjä et al. JOURNAL OF ADOLESCENT HEALTH
- Type‐Specific Duration of Human Papillomavirus Infection: Implications for Human Papillomavirus Screening and Vaccination
- (2008) Helen Trottier et al. JOURNAL OF INFECTIOUS DISEASES
- Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection
- (2008) Aline Simen-Kapeu et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine
- (2008) Elmar A. Joura et al. VACCINE
- Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study
- (2008) Loretta Brabin et al. BMJ-British Medical Journal
- Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines
- (2007) Cosette M. Wheeler et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now